S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Deep Track Capital/Q1 2022

Deep Track Capital

Periodo: Q1 2022 Β· Depositato: 2022-05-16
Vedi su SEC EDGAR β†—
AUM
$1.56B
Valore totale del portafoglio
Posizioni
52
Titoli dichiarati
Prima Posizione
NVCR
5.3% $82.8M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2022-05-16) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
NVCRNOVOCURE LTD$82.8M5.31%$82.85$17.20-79.2%
5.3%
BCYCBICYCLE THERAPEUTICS PLC$81.4M5.22%$43.88$4.35-90.1%
5.2%
TVTXTRAVERE THERAPEUTICS INC$80.8M5.18%$25.77$56.92+120.9%
5.2%
JAZZJAZZ PHARMACEUTICALS PLC$80.5M5.16%$155.67$243.47+56.4%
5.2%
GBTGLOBAL BLOOD THERAPEUTICS IN$79.8M5.12%β€”β€”
5.1%
FATEFATE THERAPEUTICS INC$77.5M4.97%$38.77$2.92-92.5%
5.0%
MDGLMADRIGAL PHARMACEUTICALS INC$77.1M4.95%$98.12$528.10+438.2%
5.0%
ISEEIVERIC BIO INC$75.7M4.86%β€”β€”
4.9%
ALNYALNYLAM PHARMACEUTICALS INC$75.7M4.86%$163.29$312.78+91.5%
4.9%
KROSKEROS THERAPEUTICS INC$75.1M4.81%$54.38$11.26-79.3%
4.8%
KURAKURA ONCOLOGY INC$54.9M3.52%$16.08$11.10-31.0%
3.5%
KDNYCHINOOK THERAPEUTICS INC$49.1M3.15%β€”β€”
3.1%
BEAMBEAM THERAPEUTICS INC$43.8M2.81%$57.30$34.79-39.3%
2.8%
IMVTIMMUNOVANT INC$39.8M2.55%$5.51$38.79+604.0%
2.5%
RPTXREPARE THERAPEUTICS INC$37.9M2.43%β€”β€”
2.4%
FDMT4D MOLECULAR THERAPEUTICS IN$37.0M2.37%$15.12$13.00-14.0%
2.4%
AGENAGENUS INC$34.4M2.21%$48.28$3.49-92.8%
2.2%
CRNXCRINETICS PHARMACEUTICALS IN$33.8M2.17%$21.95$42.23+92.4%
2.2%
DYNDYNE THERAPEUTICS INC$33.7M2.16%$9.64$23.07+139.3%
2.2%
JNCEJOUNCE THERAPEUTICS INC$28.9M1.85%β€”β€”
1.9%
ESPRESPERION THERAPEUTICS INC NE$27.8M1.79%$4.64$3.16-31.9%
1.8%
KALVKALVISTA PHARMACEUTICALS INC$25.5M1.64%$14.74β€”
1.6%
NKTXNKARTA INC$24.1M1.54%$11.38$3.22-71.7%
1.5%
DICEDICE THERAPEUTICS INC$23.9M1.53%β€”β€”
1.5%
SAGESAGE THERAPEUTICS INC$22.3M1.43%β€”β€”
1.4%
TCDAQTRICIDA INC$21.8M1.40%β€”β€”
1.4%
VRDNVIRIDIAN THERAPEUTICS INC$21.6M1.39%$18.49$19.40+4.9%
1.4%
SLNSILENCE THERAPEUTICS PLC$18.1M1.16%$19.00$10.39-45.3%
1.2%
MGTAMAGENTA THERAPEUTICS INC$15.5M1.00%β€”β€”
1.0%
FMTXFORMA THERAPEUTICS HLDGS INC$15.4M0.99%β€”β€”
1.0%

AttivitΓ  Trimestre su Trimestre

Q1 2022 vs. Q4 2021

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
AGENAGENUS INC$34.4M-92.8%
FMTXFORMA THERAPEUTICS HLDGS INC$15.4M
ENTAENANTA PHARMACEUTICALS INC$14.2M
ANABANAPTYSBIO INC$13.8M
HOOKHOOKIPA PHARMA INC$11.5M
RXDXPROMETHEUS BIOSCIENCES INC$9.3M
NUVBNUVATION BIO INC$6.1M
RLMDRELMADA THERAPEUTICS INC$2.8M

Posizioni Chiuse (8)

TickerEmittenteNozionale
RNAMAVIDITY BIOSCIENCES INC$23.8M
ACADACADIA PHARMACEUTICALS INC$23.3M
KRTXKARUNA THERAPEUTICS INC$17.1M
SRRASIERRA ONCOLOGY INC$13.2M
ATRAATARA BIOTHERAPEUTICS INC$11.8M
ASNDASCENDIS PHARMA A/S$10.8M
VNDAVANDA PHARMACEUTICALS INC$7.8M
VNDAVANDA PHARMACEUTICALS INC$7.8M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
ALNYALNYLAM PHARMACEUTICALS INC$73.7M+3862.9%+91.5%
FATEFATE THERAPEUTICS INC$53.1M+378.4%-92.5%
IPSCCENTURY THERAPEUTICS INC$7.7M+270.6%
NKTRPUTNEKTAR THERAPEUTICS$-1.4M+100.0%
NVCRNOVOCURE LTD$41.6M+81.8%-79.2%
SAGESAGE THERAPEUTICS INC$5.3M+68.8%
BCYCBICYCLE THERAPEUTICS PLC$14.5M+68.7%-90.1%
GRTSQGRITSTONE BIO INC$-10.5M+68.5%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
VERVVERVE THERAPEUTICS INC$-16.1M-79.5%
PTGXPUTPROTAGONIST THERAPEUTICS INC$-10.9M-64.8%
RFLRAFAEL HLDGS INC$-1.2M-63.5%
TNYATENAYA THERAPEUTICS INC$-8.0M-28.3%
CRNXCRINETICS PHARMACEUTICALS IN$-20.1M-18.9%+92.4%
FULCFULCRUM THERAPEUTICS INC$2.1M-13.3%
VRDNVIRIDIAN THERAPEUTICS INC$-4.8M-12.4%+4.9%
DICEDICE THERAPEUTICS INC$-10.0M-6.8%
← Torna agli Hedge Fund